/
/
/

Eiko Lifesciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018
₹17 Cr₹18 Cr₹12 Cr₹12 Cr₹11 Cr₹11 Cr₹7 Cr₹8 Cr₹11 Cr₹84 L₹56 L₹62 L₹3 Cr₹4 Cr₹2 Cr₹1 Cr₹88 L₹1 Cr₹1 Cr
₹41 L₹13 L₹32 L₹26 L₹27 L₹23 L₹9 L₹13 L₹26 L₹1 L₹5 L-₹4 L₹1 L₹5 L₹3 L₹3 L₹0₹2 L₹1 L
₹17 Cr₹18 Cr₹12 Cr₹12 Cr₹11 Cr₹12 Cr₹8 Cr₹8 Cr₹11 Cr₹85 L₹61 L₹58 L₹3 Cr₹4 Cr₹2 Cr₹1 Cr₹88 L₹1 Cr₹1 Cr
₹15 Cr₹16 Cr₹10 Cr₹10 Cr₹9 Cr₹10 Cr₹7 Cr₹8 Cr₹11 Cr₹93 L₹46 L₹2 Cr₹5 Cr₹6 Cr₹3 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹73 L₹55 L₹66 L-₹4 L₹18 L-₹96 L-₹1 Cr-₹2 Cr-₹39 L-₹33 L-₹12 L-₹15 L-₹9 L
₹13 L₹12 L₹7 L₹10 L₹5 L₹7 L₹3 L₹4 L₹3 L₹10 L₹70,000₹3 L₹8 L₹6 L₹7 L₹15 L₹2 L₹5 L₹4 L
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹54 L₹35 L₹46 L-₹18 L₹14 L-₹1 Cr-₹1 Cr-₹2 Cr-₹50 L-₹60 L-₹18 L-₹24 L-₹18 L
₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹40 L₹26 L₹35 L-₹13 L₹10 L-₹74 L-₹1 Cr-₹1 Cr-₹37 L-₹45 L-₹14 L-₹17 L-₹13 L

Share Price Live Stats

Open (₹)47.30
Volume (₹)364.00
High (₹)47.30
Upper Circuit55.83
Low (₹)46.01
Lower Circuit37.23
Prev Close46.53
52W High (₹)64.44
Price46.64
52W Low (₹)44.75

Share Market Cap & Key Ratios Overview

M.Cap (₹)68.17 Cr
Div. Yield (%)0.00
PE Ratio13.39
Debt to Equity0.05
Price to Book1.27
Book Value41.26
EPS (TTM)3.47
Face Value10.00
ROE (%)7.76

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SOLARINDS-ANSE
PIDILITIND-ANSE
SRF-ANSE
FLUOROCHEM-ANSE
NAVINFLUOR-ANSE
GODREJIND-ANSE
DEEPAKNTR-ANSE
AETHER-ANSE
ATUL-ANSE
AARTIIND-ANSE
EIKO-XNSE
LTP
1W Low
1W High
Market cap (₹)
21495.2+1115.2 (5.47%)
19810.05
21699.85
1,93,746Cr
1629.45+0.55 (0.03%)
1613.50
1691.65
1,66,118Cr
2566.55-28.25 (-1.09%)
2533.20
2648.95
77,219Cr
4609.05-164.85 (-3.45%)
4553
4848
51,537Cr
8655.95+144.65 (1.70%)
8281.95
8733.30
44,624Cr
1166.55-2.05 (-0.18%)
1128.55
1217.40
38,937Cr
1727.25-35.8 (-2.03%)
1708
1820
23,559Cr
1643.4-53.4 (-3.15%)
1625
1708.95
21,984Cr
6416.95-38.4 (-0.59%)
6370.95
6630
19,036Cr
502.05-38.35 (-7.10%)
496.05
540
18,200Cr
46.64-1.35 (-2.81%)
45.50
48.49
68Cr

Key Highlights of Eiko Lifesciences Ltd’s P&L

In 2025-03-31, Eiko Lifesciences Ltd reported total revenue of ₹38.38Cr, compared with ₹10.41Cr in 2020-03-31, reflecting Eiko Lifesciences Ltd turnover.

Depreciation was ₹73.72Lakh and finance costs were ₹16.52Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹3.06Cr in 2025-03-31 as compared to ₹-₹4.93Cr in 2020-03-31.

Net Profit (PAT) was ₹2.11Cr in 2025-03-31 compared with ₹-₹1.91Cr in 2020-03-31.

Earnings per share (EPS) were ₹1.53 in 2025-03-31, compared with ₹-4.99 in 2020-03-31.